エピソード

  • Lysins: A Next Generation Treatment Option for PJI? Part 1

    Lysins: A Next Generation Treatment Option for PJI? Part 1
    2026/06/23

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD in part 1 of this 2-part conversation on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here
    続きを読む 一部表示
    27 分
  • ICM Guidelines Discussion: "Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?" Part 2

    ICM Guidelines Discussion: "Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?" Part 2
    2026/06/09

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with P. Maxwell Courtney, MD, Katherine Belden, MD, Poorani Sekar, MD on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com.

    FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
    続きを読む 一部表示
    28 分
  • ICM Guidelines Discussion: "Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?" Part 1

    ICM Guidelines Discussion: "Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?" Part 1
    2026/05/19

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with P. Maxwell Courtney, MD, Katherine Belden, MD, and Poorani Sekar, MD in part 1 of this 2-part conversation on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com.

    FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
    続きを読む 一部表示
    27 分
  • ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?" Part 2

    ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?" Part 2
    2026/05/05

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Michael Henry, MD and Daisuke Furukawa, MD on the topic of Suppressive Antibiotic Therapy (SAT) at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.
    続きを読む 一部表示
    27 分
  • ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?" Part 1

    ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?" Part 1
    2026/04/21

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Michael Henry, MD and Daisuke Furukawa, MD in part 1 of this 2-part conversation on the topic of Suppressive Antibiotic Therapy at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com

    FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
    続きを読む 一部表示
    30 分
  • ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2

    ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2
    2026/04/07

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.

    FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
    続きを読む 一部表示
    28 分
  • ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1

    ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1
    2026/03/24

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD in part 1 of this 2-part conversation on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com

    FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
    続きを読む 一部表示
    27 分
  • Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 2

    Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 2
    2026/03/10

    In the final episode of this 2-part series, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation on Shoulder PJI definition evolution with Surena Namdari, MD, and Jason Hsu, MD. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.
    続きを読む 一部表示
    29 分